Our solutions enable you to minimize risks in drug development, streamline productivity and lower cost across key aspects of pre-clinical and clinical development, Portfolio Strategy, and Business Development.
Mispriced risk: Finding undervalued biopharma business development opportunities
AI can deliver better healthcare and longevity for all. Here's how.
The 130+ AI startups reinventing healthcare
Intelligencia Demo at CB Insights Future of Health 2021
Vangelis Vergetis presenting at the 2021 CNS Summit
Intelligencia Raises $12M to Reduce the Risk of Clinical Research, Improve R&D Productivity, and Accel erate Scientific Breakthroughs
America’s most promising AI companies of 2021
Assessing drug development risk using Big Data and Machine Learning
A Machine Learning approach for assessing drug development risk
Harnessing the Power of AI in Greece: Embarking on the Path to Value
Intelligencia.ai: Machine learning: A Catalyst for Drug Development
Take the risk out of clinical drug development
Optimizing Real World Data for Therapeutic Development: The Role of Artificial Intelligence
Dimitrios Skaltsas: AI at the heart of drug-development company